How is overdrive pacing performed in a hemodynamically stable patient with monomorphic ventricular tachycardia and a pulse of 200 beats per minute?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Overdrive Pacing for Hemodynamically Stable Monomorphic VT at 200 bpm

For hemodynamically stable monomorphic ventricular tachycardia at 200 bpm, transvenous catheter overdrive pacing is a Class IIa recommendation (reasonable) when the VT is refractory to cardioversion or frequently recurrent despite antiarrhythmic medications 1.

When to Consider Overdrive Pacing

Overdrive pacing is not a first-line therapy. The treatment hierarchy for stable monomorphic VT is:

  1. First-line: IV procainamide (Class IIa) 1
  2. Second-line: IV amiodarone for refractory or recurrent VT (Class IIa) 1
  3. Third-line: Transvenous catheter pace termination (Class IIa) 1

Overdrive pacing becomes reasonable when:

  • VT is refractory to cardioversion attempts
  • VT recurs frequently despite antiarrhythmic medication
  • The patient remains hemodynamically stable enough to tolerate the procedure

Technical Approach to Overdrive Pacing

Equipment Setup

  • Transvenous pacing catheter positioned in the right ventricle (apex or outflow tract)
  • External pacemaker capable of rapid pacing rates
  • Continuous ECG monitoring and defibrillator immediately available

Pacing Parameters

Rate Selection:

  • Pace at 10-20% faster than the VT rate
  • For VT at 200 bpm, start pacing at 220-240 bpm (cycle length ~250-270 ms)
  • External noninvasive pacing has been used at 200 pulses per minute with 120 mA amplitude 2

Pacing Modes: Two approaches have comparable efficacy 3:

  • Burst pacing: Fixed rapid rate for 5-10 seconds
  • Autodecremental (ramp) pacing: Progressively faster rates

Both modes show 93-96% efficacy for spontaneous VT (significantly higher than the 68-76% for induced VT in EP studies) 3.

Procedure Steps

  1. Confirm diagnosis: Ensure wide-complex tachycardia is VT, not SVT with aberrancy (Class I) 1

  2. Assess hemodynamic stability: Patient must maintain adequate blood pressure and consciousness. At 200 bpm with hemodynamic stability, you have a narrow window before deterioration.

  3. Position pacing catheter: Transvenous approach via femoral or internal jugular vein to RV apex

  4. Initiate overdrive pacing:

    • Start at 220-240 bpm for 5-10 seconds
    • Capture must be confirmed on ECG
    • Abruptly terminate pacing
  5. Assess response:

    • Success: Return to sinus rhythm
    • Failure: VT continues at same rate
    • Acceleration: VT accelerates or degenerates to polymorphic VT/VF (occurs in ~6% of induced VT, but only 0.01% of spontaneous VT) 3

Critical Caveats and Pitfalls

Risk of Acceleration

  • Tachycardia acceleration risk is LOW for spontaneous VT (0.01%) compared to induced VT (6%) 3
  • However, immediate cardioversion capability must be available at bedside
  • If VT accelerates or patient becomes unstable, immediately cardiovert (Class I) 1

When NOT to Use Overdrive Pacing

Absolute contraindications:

  • Polymorphic VT - requires immediate cardioversion, not pacing 1
  • Hemodynamically unstable VT - cardiovert immediately (Class I) 1
  • VT rate >150 bpm with any hemodynamic compromise 4

Relative contraindications:

  • No available transvenous access
  • Lack of immediate cardioversion capability
  • VT has not failed initial pharmacologic therapy

Alternative Consideration

For VT at 200 bpm that is truly stable, synchronized cardioversion remains highly effective and may be preferable to the time and risk of establishing transvenous pacing access 1. The 2006 ACC/AHA/ESC guidelines note that cardioversion "avoids complications associated with antiarrhythmic drug therapy" 1.

Practical Reality Check

In real-world practice, monomorphic VT at 200 bpm is at the threshold of hemodynamic tolerance. Most clinicians would:

  1. Attempt IV procainamide first (20-30 mg/min up to 17 mg/kg) while preparing for cardioversion 1
  2. If procainamide fails and patient remains stable, proceed to synchronized cardioversion rather than attempting transvenous pacing
  3. Reserve overdrive pacing for recurrent VT that repeatedly returns after cardioversion despite antiarrhythmics 1

The guideline evidence supports overdrive pacing primarily for refractory/recurrent VT, not as initial therapy 1. At 200 bpm, the window for intervention is narrow, and cardioversion is faster and more definitive.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.